Benjamin Suratt

Title: The Innovations of Benjamin Suratt

Introduction

Benjamin Suratt is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of multispecific binding proteins. His work focuses on innovative solutions for treating autoimmune diseases.

Latest Patents

Benjamin Suratt holds a patent for CD28/OX40 bispecific antibodies. This patent describes multispecific binding proteins that include a first antigen binding domain (ABD) with binding specificity to CD28 and a second ABD with binding specificity to OX40. These proteins are designed to provide new methods for treating autoimmune diseases, showcasing his commitment to advancing medical science.

Career Highlights

Suratt is currently employed at Sanofi, a leading global biopharmaceutical company. His role involves research and development in the field of immunology, where he applies his expertise to create innovative therapeutic solutions. His work has the potential to impact many lives by addressing complex health issues.

Collaborations

Throughout his career, Benjamin has collaborated with notable colleagues such as Gerald Beste and Yanik Bruynooghe. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Benjamin Suratt's contributions to the field of biotechnology, particularly through his patent on CD28/OX40 bispecific antibodies, highlight his role as a key innovator in medical research. His work at Sanofi and collaborations with esteemed colleagues further emphasize his commitment to advancing healthcare solutions.